Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 22;9(9):10030-10048.
doi: 10.1021/acsomega.3c09780. eCollection 2024 Mar 5.

A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer

Affiliations
Review

A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer

Sudharshan Reddy Dachani et al. ACS Omega. .

Abstract

Skin cancer (SC) poses a global threat to the healthcare system and is expected to increase significantly over the next two decades if not diagnosed at an early stage. Early diagnosis is crucial for successful treatment, as the disease becomes more challenging to cure as it progresses. However, identifying new drugs, achieving clinical success, and overcoming drug resistance remain significant challenges. To overcome these obstacles and provide effective treatment, it is crucial to understand the causes of skin cancer, how cells grow and divide, factors that affect cell growth, and how drug resistance occurs. In this review, we have explained various therapeutic approaches for SC treatment via ligands, targeted photosensitizers, natural and synthetic drugs for the treatment of SC, an epigenetic approach for management of melanoma, photodynamic therapy, and targeted therapy for BRAF-mutated melanoma. This article also provides a detailed summary of the various natural drugs that are effective in managing melanoma and reducing the occurrence of skin cancer at early stages and focuses on the current status and future prospects of various therapies available for the management of skin cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Formation of the tumor and its entry through the leaky vasculature of cells and major causes of skin cancer (created with BioRender.com).
Figure 2
Figure 2
An illustrative image describes the pathogenesis of skin cancer, which is mainly observed due to UV rays (UVA and UVB); direct or indirect damage to DNA then produces oxidative stress, inflammation, mutation, and immunosuppression (created with BioRender.com).
Figure 3
Figure 3
A pie illustration describes the main natural drugs and their mechanism for the treatment of skin cancer (created with BioRender.com).
Figure 4
Figure 4
Illustration of the mechanism of photodynamic therapy in the management of skin cancer (created with BioRender.com).

Similar articles

Cited by

References

    1. Kaleem M.; Perwaiz M.; Nur S. M.; Abdulrahman A. O.; Ahmad W.; Al-Abbasi F. A.; Kumar V.; Kamal M. A.; Anwar F. Epigenetics of Triple-Negative Breast Cancer via Natural Compounds. Curr. Med. Chem. 2022, 29 (8), 1436–1458. 10.2174/0929867328666210707165530. - DOI - PubMed
    1. Kaleem M.; Dalhat M. H.; Azmi L.; Asar T. O.; Ahmad W.; Alghanmi M.; Almostadi A.; Zughaibi T. A.; Tabrez S. An Insight into Molecular Targets of Breast Cancer Brain Metastasis. Int. J. Mol. Sci. 2022, 23 (19), 11687.10.3390/ijms231911687. - DOI - PMC - PubMed
    1. Valencia D. N. Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2. Cureus. 2020, 12 (3), e738610.7759/cureus.7386. - DOI - PMC - PubMed
    1. Jabbarzadeh Kaboli P.; Salimian F.; Aghapour S.; Xiang S.; Zhao Q.; Li M.; Wu X.; Du F.; Zhao Y.; Shen J.; Cho C. H.; Xiao Z. Akt-Targeted Therapy as a Promising Strategy to Overcome Drug Resistance in Breast Cancer – A Comprehensive Review from Chemotherapy to Immunotherapy. Pharmacol. Res. 2020, 156, 10480610.1016/j.phrs.2020.104806. - DOI - PubMed
    1. Dhanyamraju P. K.; Patel T. N. Melanoma Therapeutics: A Literature Review. J. Biomed. Res. 2022, 36 (2), 77–97. 10.7555/JBR.36.20210163. - DOI - PMC - PubMed

LinkOut - more resources